Immunohistochemical staining demonstrated that the tumor was positive for MSH2 and MSH6 and negative for MLH1 and PMS2 (Fig. 3), which was in agreement with the germline mutation in MLH1. A microsatellite instability analysis using the National Cancer Institute panel revealed that the tumor had high microsatellite instability. The gene discussed is MSH2; the disease is neoplasm.